News
February 28, 2008
With today’s consumer demanding more effective, less aggressive, drug-free skin treatments with no down-time, Omnilux is rewriting the rule books. More than 3,300 physicians worldwide use Omnilux light therapy in their practice, and now the consumer has the chance to bring this cutting edge technology into their home.
Freeport, NY—February 4, 2008—AGI Dermatics, the bio-pharmaceutical laboratory that pioneered DNA research for skin care, will introduce four innovative products to the Remergent line: Advanced Retinol Therapy (1% retinol), Progressive Retinol Complex (0.4% retinol), Clarifying Concentrate2 and Complete Cleanser.
DUSA Pharmaceuticals, Inc.® announced recently results from its Phase IIB clinical trial to compare the safety and efficacy of photodynamic therapy (PDT) using DUSA's BLU-U® brand light plus vehicle containing Levulan® (aminolevulinic acid HCl) to that of PDT using the BLU-U plus vehicle without Levulan (the "control group") in patients with moderate to severe facial acne vulgaris. The study demonstrated that both treatments were safe and well tolerated with no serious adverse events.
A new cosmetic oxygen treatment, Oxy-Mist developed by Sandra Hayman of biO2 Cosmeceuticals, improves post laser resurfacing healing time, minimizes pain and decreases the period of post-operative erythema.
Lescarden’s Catrix® Wound Dressing can provide clinicians with a viable non-surgical alternative to skin grafting for children suffering from second and third degree burns. This study was conducted at the Burn Center of Bestian Medical Center, Seoul, Korea.
PhotoMedex, Inc. today announced the signing of a definitive purchase agreement to acquire Photo Therapeutics for $13 million in cash at closing, and up to an additional $7 million.
Eleme Medical Inc. announced today that Gary D. Hall, MD, will be the first Kansas City plastic surgeon to offer the SmoothShapes® system for longer-lasting cellulite treatment at Rajeunir Medical Spas in Leawood, Lee's Summit and Northland Kansas City.
NeoStrata today announced findings from an ongoing 12-week study that demonstrates benefits of a novel topically applied LCD (coal tar) solution (Psorent™) versus calcipotriol cream (Dovonex®) in treatment of moderate plaque psoriasis. Specifically, results of an interim analysis reveal the LCD solution is outperforming calcipotriol cream in achieving improvement of psoriasis symptoms (PASI 75) and is significantly better in reducing redness/irritation at both the 2- and 12-week point.
The American Academy of Dermatology is holding the Summer Academy Meeting 2008, its annual summer scientific meeting, in Chicago, July 30 - August 3, 2008, at the Hyatt Regency Chicago, 151 West Wacker Drive. World-renowned leaders in the field of dermatology are presenting information on the latest research in the diagnosis and medical, surgical and cosmetic treatment of skin, hair and nail conditions. Anticipated attendance is more than 4,000.
Designed to treat smaller areas on the body, such as the neck, jowls and chin, CoolTouch Inc.’s CoolLipo is an advanced technology that tightens skin while it eliminates fat during a procedure called laser-assisted lipolysis.
